MSR95 Use of Generalized F Parameterization in Long-Term Extrapolation for Adjuvant Cancer Therapies

Autor: R Young, K Padgett, T Brown, O Moseley, T Krieger, F Toron, S Kassahun, B Jones

Publikováno v: Value in Health. 25:S368

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1479cef5122e36722597e139c645a882
https://doi.org/10.1016/j.jval.2022.09.1826

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Real-world outcomes of patients with relapsed/refractory large B-cell lymphoma receiving second-line therapy in England.

Autor: Fox CP; School of Medicine University of Nottingham Nottingham UK., Townsend W; University College London Hospitals NHS Foundation Trust London UK., Gribben JG; Barts Cancer Institute Barts Health NHS Trust London UK., Menne T; Newcastle upon Tyne Hospitals NHS Foundation Trust Newcastle upon Tyne UK., Kalakonda N; Molecular & Clinical Cancer Medicine University of Liverpool Liverpool UK., Williams P; Bristol Myers Squibb Uxbridge UK., Toron F; Bristol Myers Squibb Uxbridge UK., Tyas E; Lumanity Farnham UK., Cooper M; Lumanity Farnham UK., Rickards J; Lumanity Farnham UK., Radford J; Manchester Academic Health Science Centre The Christie NHS Foundation Trust and University of Manchester Manchester UK.

Publikováno v: EJHaem [EJHaem] 2024 Aug 07; Vol. 5 (5), pp. 992-997. Date of Electronic Publication: 2024 Aug 07 (Print Publication: 2024).